The president of the Social Insurance Institute (IPS), Isaías Fretes, ordered a temporary suspension of a tender for biological and immunosuppressant drugs valued at G. 376 billion. The decision was made during a Board of Directors meeting, on the grounds that the amount is excessive and requires greater transparency and evaluation by scientific societies. In contrast, the board approved the purchase of parenteral solutions for G. 17 billion, 47% below the initial estimate.
YouTube
Plataforma de transmisión en vivo donde se emitieron las sesiones del Consejo del IPS con problemas técnicos.